Literature DB >> 32549953

Comment on "Cysteine-Targeted Insecticides against A. gambiae Acetylcholinesterase Are Neither Selective nor Reversible Inhibitors".

Yuan-Ping Pang1.   

Abstract

Entities:  

Year:  2020        PMID: 32549953      PMCID: PMC7294557          DOI: 10.1021/acsmedchemlett.0c00147

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


× No keyword cloud information.
In the article by Gorecki et al. (), the authors reported that maleimides irreversibly inhibited both the African malaria mosquito (Anopheles gambiae) Ace-paralogous acetylcholinesterase (aka agAP-AChE[1]) bearing a free Cys and the human counterpart devoid of the Cys and concluded that “Cys-targeted insecticides against A. gambiae acetylcholinesterase are neither selective nor reversible inhibitors”. This conclusion is problematic for at least six reasons. A prerequisite to claim that maleimide PM20[2] does not conjugate with the agAP-AChE Cys is to confirm that the Cys is not oxidized. However, in the Gorecki article, no evidence was provided to show that the Cys in their agAP-AChE was active for conjugation. In the Gorecki article, their agAP-AChE was claimed to be “in very good correlation” with the reported agAP-AChE[3] that was used in ref (2). However, only KM was reported for their agAP-AChE. Their omission of kcat, which is also needed for enzyme comparison, raises concerns with their specific enzyme activity. Their enzyme could be reasonably active (like crude extracts) and suitable for certain inhibitor characterizations but unsuitable for the kinetic characterization of PM20 described in ref (2). In the Gorecki article, 10 μM PM20 and 10 μM paraoxon (rather than 1 nM PM20 and 200 nM paraoxon in ref (2)) showed no agAP-AChE activity recovery after dialysis. Using higher inhibitor concentrations here would prompt for determining the specific enzyme activity at the time when the assay was performed. However, no specific enzyme activity was reported in the Gorecki article. This substantiates the activity concerns above. Potential irreversible inhibitors can be identified by their progressive inhibition from reversible inhibitors that exhibit constant inhibition in a time-course experiment. This requires controls at proper concentrations to define a period of time over which the progressive inhibition can be observed. Using high inhibitor concentrations can make the progressive inhibition period too short to practically measure the enzyme activity over the period. In ref (2), 6 nM PM20, 300 nM PMS20, and 700 nM paraoxon showed 20–30% agAP-AChE inhibition after 3 min, and then PM20 and paraoxon showed progressive agAP-AChE inhibition over the 3–15 min period, whereas PMS20 showed constant 20% agAP-AChE inhibition over the same period, wherein PMS20 (a maleimide-free analog of PM20) and paraoxon (known to conjugate with the catalytic Ser of cholinesterases) were controls to show respective constant and progressive inhibitions. In the Gorecki article, 800 nM PM20 exhibited nearly constant agAP-AChE inhibition over the 3–15 min period in their experiment without using known inhibitors (e.g., PMS20 and paraoxon) to show that their experimental conditions are suitable to observe constant and progressive inhibitions. The use of a high PM20 concentration and the lack of controls raise concerns about their study design. The conclusion of the Gorecki article regarding inhibitor selectivity is IC50-based and contradicts the textbook[4] on irreversible inhibitor evaluation using kinact/KI: “An important point to realize here is that attempts to quantify the relative potency of irreversible enzyme inactivators by more traditional parameters, such as IC50 values, are entirely inappropriate because these values will vary with time, in different ways for different compounds. Hence the SAR derived from IC50 values, determined at a fixed time point in the reaction progress curve, is meaningless and can be misleading in terms of compound optimization.” Maleimides are nonselective alkylating agents that have never been used as insecticides. PM20 was intended only for mass spectrometric evidence for Cys conjugation with agAP-AChE.[2] Equating maleimides with “Cys-targeted insecticides” in the Gorecki article is improper and misleading.
  4 in total

1.  Evaluation of enzyme inhibitors in drug discovery. A guide for medicinal chemists and pharmacologists.

Authors:  Robert A Copeland
Journal:  Methods Biochem Anal       Date:  2005

2.  Cysteine-Targeted Insecticides against A. gambiae Acetylcholinesterase Are Neither Selective nor Reversible Inhibitors.

Authors:  Lukas Gorecki; Rudolf Andrys; Monika Schmidt; Tomas Kucera; Miroslav Psotka; Barbora Svobodova; Veronika Hrabcova; Vendula Hepnarova; Petr Bzonek; Daniel Jun; Kamil Kuca; Jan Korabecny; Kamil Musilek
Journal:  ACS Med Chem Lett       Date:  2019-11-26       Impact factor: 4.345

3.  Recombinant expression and biochemical characterization of the catalytic domain of acetylcholinesterase-1 from the African malaria mosquito, Anopheles gambiae.

Authors:  Haobo Jiang; Siwei Liu; Picheng Zhao; Carey Pope
Journal:  Insect Biochem Mol Biol       Date:  2009-07-14       Impact factor: 4.714

4.  Novel selective and irreversible mosquito acetylcholinesterase inhibitors for controlling malaria and other mosquito-borne diseases.

Authors:  Dengfeng Dou; Jewn Giew Park; Sandeep Rana; Benjamin J Madden; Haobo Jiang; Yuan-Ping Pang
Journal:  Sci Rep       Date:  2013-01-15       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.